In the News

Share

Connect with us

Stay Informed.

Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
COVID-19: Information for Patients and Caregivers

We're here for you, and continue to provide cancer care to new and current patients. Learn about our response to COVID-19.

What you need to know

1661 News Items found
MSK thoracic surgeon Prasad Adusumilli
New Design Could Make CAR T Cells a More Effective Immunotherapy for Solid Tumors

Learn how researchers engineered CAR T cells to work better by using a mutation in a gene called c-KIT that drives cancer cell growth.
Susan Everson, a transgender woman, was treated at MSK for stage 3 colorectal cancer. She says her care team made her feel welcome, in addition to offering her the most advanced therapies. Susan is now cancer free.
Being Seen: Compassionate Cancer Treatment for Transgender People

Learn how MSK cares for transgender cancer patients, treating them with respect and medical expertise. Staff are specially trained to understand their needs.
Feature
Gloved hands holding a pipette.
Your Gut Microbiome: How To Improve It, Its Effects on the Immune System, and More

This story answers common questions about how your gut microbiota impacts your health, how to protect it, and the impact it has on diseases like cancer.
A breast cancer cell containing micronuclei
MSK-Led Research Finds Unexpected Link Between Chromosomal Instability and Epigenetic Alterations

MSK-led research found an unexpected link between chromosomal instability and epigenetic alternations, both of which are hallmarks of cancer — especially advanced, drug-resistant cancers.
Kieran Healy is seen smiling outdoors next to his bike, after successful treatment for lymphoma at Memorial Sloan Kettering.
How MSK’s Rapid Diagnosis Got Kieran Treated Quickly for Lymphoma

Kieran Healy was feeling worse by the day. A new father at 43 years old, he was bone-tired and losing weight. He had night sweats and a strange lump in his belly. His local hospital in Manhattan ordered an ultrasound and a CT (computed tomography) scan — but they were scheduled over a month away.
Feature
Dr. Alicia Latham, Dr. Michael Walsh, Dr. Zsofia Stadler, and Megha Ranganathan
Inherited Cancer Risks: New Insights from MSK Presented at 2023 ASCO Meeting

MSK investigators are leading research focused on understanding how hereditary DNA mutations affect cancer development and therapy, and how to best treat people who carry these inherited risks in their genes.
MSK neuro-oncologist Ingo Mellinghoff
Experimental Drug for Low-Grade Glioma With IDH Gene Mutation Shows Promise

A new experimental drug could be an effective treatment for some people with low-grade glioma.
See Dr. Deb Schrag standing in a hallway. She led a clinical trial involving rectal cancer at Memorial Sloan Kettering.
Rectal Cancer Treatment Without Radiation: A New Option

Learn about a clinical trial at Memorial Sloan Kettering that gives people with rectal cancer a new option to be treated without radiation. The research shows that a well-known chemotherapy regimen used alone can be just as effective as chemotherapy given with radiation before surgery. The new method may reduce side effects associated with radiation such as loss of fertility and impaired bladder and sexual function.
Dr. James Harding
For Advanced, HER2-Amplified Bile Duct Cancers, Antibody Treatment Trial Shows Promising Results

New research finds an antibody treatment helped shrink tumors in some patients with bile duct cancers — specifically a subset of people whose tumors make a high amount of the HER2 protein, which can cause cells to multiply too quickly.
In the Lab
Dr. Piro Lito
Potential Drug Shows Promise Targeting a Range of KRAS-Driven Cancers in the Lab

MSK investigators report exciting results for a new molecule that can block 16 different mutated forms of the KRAS protein. In the lab, the compound was effective against many cancer cell lines and in mouse models of lung cancer and colorectal cancer.